Brief Research Report
Accepted on 28 Feb 2025
Targeting CCRL2 enhances therapeutic outcomes in a tuberculosis mouse model
Frontiers in Immunology
doi 10.3389/fimmu.2025.1501329
Volumes
42,420 Publications
Volume 16 - 2025
Mini Review
Accepted on 28 Feb 2025
ZNFX1: A multifunctional modulator of the innate immune response
Frontiers in Immunology
doi 10.3389/fimmu.2025.1564628
Case Report
Accepted on 28 Feb 2025
Case Report: Anti-Yo Antibody Mediated Paraneoplastic Cerebellar Degeneration in A Patient with Squamous Cell Lung Carcinoma
Frontiers in Immunology
doi 10.3389/fimmu.2025.1558867
Original Research
Accepted on 28 Feb 2025
Miquelianin inhibits IAV infection via the MAPK signaling pathway both in vitro and in vivo
Frontiers in Immunology
doi 10.3389/fimmu.2025.1532336
Original Research
Accepted on 28 Feb 2025
Increased circulating levels of SP-D and IL-10 are associated with the development of disease severity and pulmonary fibrosis in patients with COVID-19
Frontiers in Immunology
doi 10.3389/fimmu.2025.1553283
Original Research
Accepted on 28 Feb 2025
Brain injury, endocrine disruption, and immune dysregulation in HIV-positive men who have sex with men with late HIV diagnosis
Frontiers in Immunology
doi 10.3389/fimmu.2025.1436589
Systematic Review
Accepted on 28 Feb 2025
The modified parts have been marked in red font, comments have been added in some places to provide explanations
Frontiers in Immunology
doi 10.3389/fimmu.2025.1538969
Original Research
Accepted on 28 Feb 2025
Integration of histopathological images and immunological analysis to predict M2 macrophage infiltration and prognosis in patients with serous ovarian cancer
Frontiers in Immunology
doi 10.3389/fimmu.2025.1505509
Review
Accepted on 28 Feb 2025
New player in CAR-T manufacture field: comparison of Umbilical umbilical Cord cord to Peripheral peripheral Blood blood strategies
Frontiers in Immunology
doi 10.3389/fimmu.2025.1561174
Systematic Review
Accepted on 28 Feb 2025
sCD40 and sCD40L as candidate biomarkers of rheumatic diseases: A systematic review and meta-analysis with meta-regression
Frontiers in Immunology
doi 10.3389/fimmu.2025.1479904
Review
Accepted on 28 Feb 2025
Healthy and premature aging of monocytes and macrophages
Frontiers in Immunology
doi 10.3389/fimmu.2025.1506165
Review
Accepted on 28 Feb 2025
Adoptive immune cell therapy for colorectal cancer
Frontiers in Immunology
doi 10.3389/fimmu.2025.1557906
Original Research
Accepted on 28 Feb 2025
Analysis of Shared Pathogenic Mechanisms and Drug Targets in Myocardial Infarction and Gastric Cancer Based on Transcriptomics and Machine Learning
Frontiers in Immunology
doi 10.3389/fimmu.2025.1533959
Original Research
Accepted on 28 Feb 2025
Enhancing Pancreatic Cancer Treatment: The Role of H101 Oncolytic Virus in Irreversible Electroporation
Frontiers in Immunology
doi 10.3389/fimmu.2025.1546242
Original Research
Accepted on 28 Feb 2025
Interaction Between Post-Tumor Inflammation and Vascular Smooth Muscle Cell Dysfunction in Sepsis-Induced Cardiomyopathy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1560717
Original Research
Accepted on 28 Feb 2025
Global Research Trends of Tumor Microenvironment in Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: A Bibliometric
Frontiers in Immunology
doi 10.3389/fimmu.2025.1555216